Planned sale of 2,094 shares by EQIX insider (NASDAQ: EQIX)

Rhea-AI Filing Summary

A shareholder of EQIX has filed a notice of proposed sale of 2,094 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $1,679,011.08. These shares were acquired as restricted stock units from the issuer on 01/15/2026, with payment also dated 01/15/2026. The filing notes that 98,186,078 shares of common stock were outstanding. Over the past three months, there was a separate Rule 10b5-1 transaction titled “10b5-1 Sales for CHARLES J MEYERS AND ELIZABETH L MEYERS JT TEN,” involving the sale of 5,087 common shares on 11/17/2025 for $3,960,071.29 in gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2094	1679011.08	98186078	01/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Restricted Stock Units	Issuer			2094	01/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHARLES J MEYERS ANDELIZABETH L MEYERS JT TEN One Lagoon Drive Redwood City CA 94065	Common	11/17/2025	5087	3960071.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for EQIX disclose?

The filing discloses a planned sale of 2,094 EQIX common shares on the NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,679,011.08.

How many EQIX shares are planned to be sold and on which exchange?

The notice covers up to 2,094 common shares of EQIX to be sold on the NASDAQ.

How were the EQIX shares in this Form 144 acquired?

The 2,094 common shares were acquired on 01/15/2026 via restricted stock units from the issuer, with payment also dated 01/15/2026.

What does the Form 144 say about EQIX shares outstanding?

The notice states that there were 98,186,078 EQIX common shares outstanding when the form was prepared.

Were there other recent EQIX share sales by the same seller?

Yes. The form lists a Rule 10b5-1 transaction titled “10b5-1 Sales for CHARLES J MEYERS AND ELIZABETH L MEYERS JT TEN,” where 5,087 common shares were sold on 11/17/2025 for $3,960,071.29 in gross proceeds.

What is the role of Rule 10b5-1 mentioned in the EQIX Form 144?

The Form 144 references “10b5-1 Sales” and includes a representation that, if relying on a written trading plan or instructions under Rule 10b5-1, the person did not know any undisclosed material adverse information about the issuer at the time the plan or instructions were adopted.